”), with 51.0% and 49.0% of registered and paid-up capital of CVHLUX as of 30 September 2017, respectively. CVHLUX is a holding company which invests in 100% share of the registered and paid-up capital of
% 652 4.2% Selling expense 11,890 18.8% 12,285 23.0% (395) (3.2%) Administrative expense 4,911 7.7% 4,043 7.6% 868 21.5% Share of profit of associates and joint ventures 79 0.1% 28 0.1% 51 185.5% Profit
ที่ FPI Ref. FPI.011/2019 14 November 2019 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2019 To : Board of Directors and President of The Stock Exchange of Thailand
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
Microsoft Word - Ref FPI.028.2017.doc Ref. FPI.028/2017 9 November 2017 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2017 To : Board of Directors and President of
amounting of 1.42 Million Baht due to the liquidity issue of LPG customers. Moreover, the Group has increased in number of staff and management to support Testing and Inspection service business, especially
Page 1 of 5 GEL.CS.021/2561 14 August 2018 Subject Management Discussion and Financial Analysis for the operating results of the second quarter of 2018, ended 30 June 2018 To Director and Manager The
, the Group has increased in number of staff and management to support Testing and Inspection service business, especially in eastern region. The staff cost has been increased 2.18 Million Baht